July 1, 2021 — The University of Oxford announced commencement of enrollment for the Phase I PanDox study of thermosensitive liposomal doxorubicin triggered by focused ultrasound in patients with pancreatic cancer.
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now